Literature DB >> 19574935

Transvaginal dehydroepiandrosterone: an unconventional proposal to deliver a mysterious androgen that has no receptor or target tissue using a strategy with a new name: hormone precursor replacement therapy (HPRT).

John E Buster.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19574935     DOI： 10.1097/gme.0b013e3181ae1fca

Source DB:  PubMed          Journal:  Menopause        ISSN： 1072-3714            Impact factor:   2.953


× No keyword cloud information.
  2 in total

1.  A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CA.

Authors:  Charles L Loprinzi; Ernie P Balcueva; Heshan Liu; Jeff A Sloan; Lisa A Kottschade; Philip J Stella; Mark D Carlson; Dennis F Moore; Robin T Zon; Ralph Levitt; Anthony J Jaslowski
Journal:  J Support Oncol       Date:  2011 May-Jun

2.  Ample Evidence: Dehydroepiandrosterone (DHEA) Conversion into Activated Steroid Hormones Occurs in Adrenal and Ovary in Female Rat.

Authors:  Yingqiao Zhou; Jian Kang; Di Chen; Ningning Han; Haitian Ma
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.